4.6 Article

Activation impairment alters muscle torque-velocity in the knee extensors of persons with post-stroke hemiparesis

Journal

CLINICAL NEUROPHYSIOLOGY
Volume 117, Issue 10, Pages 2328-2337

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.clinph.2006.07.131

Keywords

post-stroke hemiparesis; weakness; muscle; torque-velocity; EMG; hemiplegia; motor control; stroke

Ask authors/readers for more resources

Objective: To elucidate mechanisms of impaired force production in post-stroke hemiparesis. Methods: Knee extensor torque-velocity and activation-velocity relationships were examined in seventeen persons with post-stroke hemiparesis (age 57.5, +/- 6.9) and thirteen non-disabled (age 63.0 +/- 10.4) persons. Results: Velocity-dependent concentric torque impairment was exaggerated in subjects with hemiparesis relative to control subjects (p < .001). Muscle power was also less in the group with hemiparesis (p < .001), and plateaued at velocities >= 90 deg/s (p > .05). In the control group agonist EMG during concentric actions exhibited a positive linear relationship as velocity increased (R-2 = .93, p < .05). The group with hemiparesis produced 34-60% less agonist EMG than controls (p < .02) and modulation was absent (p > .05). Antagonist EMG was either greater in the control (biceps femoris, p < .006) or similar between groups (semimembranosus, p = .95). Under eccentric testing conditions, torque normalized to peak isometric torque (p = .44) and rectus femoris activation (p = .33) were similar between groups, indicating a relative preservation of eccentric torque producing capacity post-stroke. Conclusions: Certain clinical perspectives assert that weakness following central nervous system injury stems from spastic antagonist restraint. Instead, absence of an antagonist restraint strongly suggests that impaired agonist activation is the principal determinant of hemiparetic weakness. Significance: These findings have important implications for promoting optimal recovery of motor function in neuro-rehabilitation. (c) 2006 Published by Elsevier Ireland Ltd on behalf of International Federation of Clinical Neurophysiology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available